Advancing healthcare policy

Via its policy advocacy, Prescrire acts as a force for change in health policies, first and foremost in the interest of patients

image of Advancing healthcare policy

Working together with other organisations, Prescrire‘s policy advocacy is a source of constructive proposals, counterbalancing the influence of purely commercial interests.

Prescrire Actions presented by theme

  • Clinical trials and Europe
    The central issues in the debate surrounding the 2014 European Clinical Trials Regulation: protecting participants, and an international campaign for clinical data transparency.
  • Transparent, independent health authorities
    To act first and foremost in the interests of citizens, drug regulatory agencies must develop independent decision-making processes and a culture of transparency towards data.
  • Pharmacovigilance
    Public health disasters are a constant reminder of the need for independent and proactive pharmacovigilance. Yet under the recent reorganisation of European pharmacovigilance, this crucial public health mission is increasingly outsourced to drug companies.
  • Medical devices and Europe
    The overhaul of the European legislative framework for medical devices offers an opportunity to improve patient safety, notably by requiring that high-risk medical devices undergo clinical evaluation before they can be placed on the market.
  • Drug packaging and patient safety
    A drug’s packaging is an important component of its harm-benefit balance. Quality packaging encourages proper use of medicines, and allows many errors to be avoided.
  • The INN, a drug’s real name
    INNThe readily intelligible language of the International Nonproprietary Name (INN) makes for clear thinking, protects patient safety and encourages rational use of medicines, free from influence.
  • Direct-to-consumer advertising (DTCA) disguised as patient “information” [2007-2012]
    To ensure that patients’ rights are respected: yes to reliable independent information, no to direct-to-consumer advertising (DTCA) masquerading as “information”, “compliance support” or other types of “health education” programmes.
  • The Medicines in Europe Forum: actions by the network
    The European legislative framework impacts the level of guarantees afforded to citizens of the European Union in terms of the quality and safety of their healthcare. It is certainly too sensitive a matter to give free rein to vested interests.

Chronological recap of Prescrire actions

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s